Advancing Drug Discovery Through Mechanistic Validation and Translational Evaluation.

OA: gold CC-BY-4.0
⚙ AI-generated summary by qwen3.7-flash, 2026-11-11 ⓘ

This special issue presents five original research articles and one narrative review examining how experimental interventions might become useful therapies through mechanistic validation and translational evaluation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-11-11 · read from full text ⓘ

This editorial serves as an introduction to a special issue focused on advancing drug discovery through mechanistic validation and translational evaluation. It acknowledges the contributions of various authors, reviewers, and funding bodies while clarifying that no new datasets were generated for this specific text. The content relies entirely on published literature cited within the broader collection rather than original experimental results. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The Special Issue "Advances in Novel Drug Discovery, Synthesis, and Evaluation" brings together five original research articles and one narrative review examining how experimental interventions might become useful therapies [...].
Full text 1,617 characters · extracted from epmc-fulltextxml · 7 sections · click to expand

Ack

The authors thank the contributing authors, reviewers, and the Biomedicines editorial team for their contributions to the Special Issue “Advances in Novel Drug Discovery, Synthesis, and Evaluation.” The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Data

No new datasets were generated or analyzed in preparing this editorial. The discussion is based on published literature cited in the manuscript. Data sharing is not applicable to this article.

Author

Conceptualization, K.M.E.; writing—original draft preparation, M.A.N. and L.M.A.; writing—review and editing, M.A.N., L.M.A. and K.M.E.; supervision, K.M.E.; funding acquisition, K.M.E. All authors have read and agreed to the published version of the manuscript.

Funding

This publication was made possible by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under Grant 2P20GM103432.

Fn Group

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Conflicts

The authors declare no conflicts of interest.

Associated Data

No new datasets were generated or analyzed in preparing this editorial. The discussion is based on published literature cited in the manuscript. Data sharing is not applicable to this article.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: epmc-fulltextxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-11-15T09:34:25.365398+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Per Europe PMC